2018 Section 5 - Rhinology and Allergic Disorders

Otolaryngology–Head and Neck Surgery 154(1)

Table 1. Study Data Available for Qualitative Analysis.

Preoperative Score a

Included

BCD Cohort, n SNOT-20

Location of BCD

Nasal Polyposis

Revision Procedures

Age, a y

Study

Intervention

LM

Abreu 19 2014 Achar 20 2012

5.2 6 2.7 39.9 6 15.6 OR

BCD

13 12 37 50 49 50 50 35 75 24 23 30

NR

N N

N N

BCD 1 ESS

3.18 6 0.75 7.92 6 4.39 38.9 6 10.9 OR 2.24 6 0.98 6.38 6 3.74 54.6 6 12.5 Office

Albritton 11 2012 b Bikhazi 21 2014 c Bolger 22 2007 d Brodner 23 2013 Cutler 24 2013 c Friedman 25 2008 Karanfilov 27 2013 b Koskinen 28 2012 e Kuhn 29 2008 d Kutluhan 30 2009 Levine 31 2008 e Luong 13 2008 e Gould 26 2014

BCD

Y

Y

BCD 1 ESS

2.54 6 0.92

NR

NR Office

N N

N

BCD 1 hybrid BCD 1 hybrid

2.14 6 0.97 8.33 (1-21) 47.8 (21-76) OR

Y

1.9 6 1.1

6.9 6 4.6 50.8 6 16.4 OR

Y

NR

BCD 1 ESS BCD 1 ESS

2.54 6 0.91 2.8 6 0.52 2.27 6 0.92 2.1 6 0.90

3.2 6 3.2 47.0 6 14.6 OR 1 office N

N

43.0 6 11.7 OR 1 office N

NR

Y

5.0 6 4.2 50.1 6 16.7 Office 6.9 6 3.60 48.6 6 15.4 Office

BCD BCD

Y Y

N

202

Y

BCD 1 ESS

46 6 23-65 OR

NR

NR

N N

N

BCD 1 hybrid BCD 1 hybrid

5.96 6 7.53

2.01

NR OR

Y

1.28 6 2.54 4.75 6 9.43 38.3 6 11.37 OR

Y Y

N

BCD 1 hybrid 328

47.2 (18-92) OR 1 office

NR NR

NR NR

Y Y

BCD

6

55 (36-68) Office

N N N

Raghunandhan 32 2013 e BCD

20 68.60%

47.70%

NR OR NR OR

N N

Weiss 33 2008 d

BCD 1 hybrid

2.07 6 1.03 5.67 6 4.58

28

Abbreviations: BCD, balloon catheter dilation; ESS, endoscopic sinus surgery; LM, Lund-Mackay; N, no; NR, not reported; OR, operating room; SNOT-20, 20-Item Sinonasal Outcome Test; Y, yes. a Values presented as mean 6 SD or mean (range), unless noted otherwise. b ORIOS study c REMODEL study. d CLEAR study. e Not included in quantitative analysis.

Table 2. Itemized Assessment of Risk of Bias for Studies Included in Systematic Review.

Direction of Inquiry

Handling of Lost Data

Basis for Treatment Allocation

Level of Evidence 18

Study

Randomization

Blinding

Abreu 19 2014 Achar 20 2012

Prospective Prospective Prospective Prospective Prospective Prospective Prospective Retrospective Prospective Prospective Retrospective Prospective Retrospective Retrospective Retrospective

No Yes No Yes No No Yes

No No No

Excluded

Not given

2b 1b 2b 1b 2b 2b 1b 2b 2b 2b 2b 2b 2b 2b 2b 2b 2b

No dropouts Random block permutation

Albritton 11 2012 Bikhazi 21 2014 Bolger 22 2007 Brodner 23 2013 Cutler 24 2013 Friedman 25 2008

Excluded

Patient and surgeon preference One-to-one randomization

Outcomes assessors Excluded

No No

Excluded Excluded

Patient preference Surgeon preference

Outcomes assessors Excluded

Random block permutation

— —

Excluded Excluded Excluded Excluded Excluded

N/A

Gould 26 2014

No No

No No

Not given

Karanfilov 27 2013 Koskinen 28 2012

Patient preference

— —

N/A

Kuhn 29 2008

No

No

Patient preference

Kutluhan 30 2009 Levine 31 2008

— — — — — —

Not given N/A Not given N/A No dropouts N/A

Luong 13 2008

Raghunandhan 32 2013 Prospective

No No

No No

Not given Patient preference

Weiss 33 2008

Prospective

Excluded

Patient preference

Abbreviation: N/A, not applicable.

218